Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 338, Issue 1, 2011, Pages 92-99

  Berg, Kelly A ^a   Rowan, Matthew P ^a   Sanchez, Teresa A ^a   Silva, Michelle ^a   Patwardhan, Amol M ^b   Milam, Stephen B ^b   Hargreaves, Kenneth M ^a,b   Clarke, William P ^a  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ADENYLATE CYCLASE; ARACHIDONIC ACID; BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; KAPPA OPIATE RECEPTOR; PROTEIN KINASE C;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MALE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SENSORY NERVE CELL; SIGNAL TRANSDUCTION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SENSORY RECEPTOR CELLS; SIGNAL TRANSDUCTION; TRIGEMINAL GANGLION;

EID: 79959509280     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.177493     Document Type: Article

References (33)

1. Ahn AH and Basbaum AI (2006) Tissue injury regulates serotonin 1D receptor expression: implications for the control of migraine and inflammatory pain. J Neurosci 26:8332-8338. (Pubitemid 44309847)
2. Berg KA, Patwardhan AM, Sanchez TA, Silva YM, Hargreaves KM, and Clarke WP (2007a) Rapid modulation of μ-opioid receptor signaling in primary sensory neurons. J Pharmacol Exp Ther 321:839-847. (Pubitemid 46762685)
3. Berg KA, Zardeneta G, Hargreaves KM, Clarke WP, and Milam SB (2007b) Integrins regulate opioid receptor signaling in trigeminal ganglion neurons. Neuroscience 144:889-897. (Pubitemid 46013994)
4. Bruchas MR and Chavkin C (2010) Kinase cascades and ligand-directed signaling at the κ-opioid receptor. Psychopharmacology (Berl) 210:137-147.
5. Busch-Dienstfertig M and Stein C (2010) Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain-basic and therapeutic aspects. Brain Behav Immun 24:683-694.
6. Corbett AD, Henderson G, McKnight AT, and Paterson SJ (2006) 75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol 147(Suppl 1):S153-S162. (Pubitemid 43077273)
7. Crain SM and Shen KF (1990) Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol Sci 11:77-81. (Pubitemid 20041666)
8. Dai Y, Iwata K, Fukuoka T, Kondo E, Tokunaga A, Yamanaka H, Tachibana T, Liu Y, and Noguchi K (2002) Phosphorylation of extracellular signal-regulated kinase in primary afferent neurons by noxious stimuli and its involvement in peripheral sensitization. J Neurosci 22:7737-7745. (Pubitemid 35386372)
9. DeHaven-Hudkins DL and Dolle RE (2004) Peripherally restricted opioid agonists as novel analgesic agents. Curr Pharm Des 10:743-757. (Pubitemid 38292402)
10. Gibbs JL, Diogenes A, and Hargreaves KM (2007) Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors. Br J Pharmacol 150:72-79. (Pubitemid 46094671)
11. Gupta A, Bodin L, Holmström B, and Berggren L (2001) A systematic review of the peripheral analgesic effects of intraarticular morphine. Anesthesia Analgesia 93:761-770. (Pubitemid 32783308)
12. Hargreaves K, Dubner R, Brown F, Flores C, and Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
13. Joris JL, Dubner R, and Hargreaves KM (1987) Opioid analgesia at peripheral sites: a target for opioids released during stress and inflammation? Anesth Analg 66:1277-1281. (Pubitemid 18024606)
14. Kalso E, Smith L, McQuay HJ, and Andrew Moore R (2002) No pain, no gain: clinical excellence and scientific rigour-lessons learned from IA morphine. Pain 98:269-275. (Pubitemid 34786657)
15. Kelly E, Bailey CP, and Henderson G (2008) Agonist-selective mechanisms of GPCR desensitization. Br J Pharmacol 153(Suppl 1):S379-S388. (Pubitemid 351340999)
16. Kivell B and Prisinzano TE (2010) Kappa opioids and the modulation of pain. Psychopharmacology (Berl) 210:109-119.
17. König C, Gavrilova-Ruch O, von Banchet GS, Bauer R, Grün M, Hirsch E, Rubio I, Schulz S, Heinemann SH, Schaible HG, et al. (2010) Modulation of μ-opioid receptor desensitization in peripheral sensory neurons by phosphoinositide 3-kinase γ. Neuroscience 169:449-454.
18. Manara L, Bianchi G, Ferretti P, and Tavani A (1986) Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites. J Pharmacol Exp Ther 237:945-949. (Pubitemid 16088118)
19. Marie N, Aguila B, and Allouche S (2006) Tracking the opioid receptors on the way of desensitization. Cell Signal 18:1815-1833. (Pubitemid 44485992)
20. Nomura K, Reuveny E, and Narahashi T (1994) Opioid inhibition and desensitization of calcium channel currents in rat dorsal root ganglion neurons. J Pharmacol Exp Ther 270:466-474. (Pubitemid 24271352)
21. Ossipov MH, Lai J, King T, Vanderah TW, Malan TP Jr, Hruby VJ, and Porreca F (2004) Antinociceptive and nociceptive actions of opioids. J Neurobiol 61:126-148. (Pubitemid 39287774)
22. Patwardhan AM, Berg KA, Akopain AN, Jeske NA, Gamper N, Clarke WP, and Hargreaves KM (2005) Bradykinin induces functional competence and trafficking of the δ-opioid receptor in trigeminal nociceptors. J Neurosci 25:8825-8832. (Pubitemid 41384450)
23. Patwardhan AM, Diogenes A, Berg KA, Fehrenbacher JC, Clarke WP, Akopian AN, and Hargreaves KM (2006) PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the δ-opioid receptor. Pain 125:114-124. (Pubitemid 44498969)
24. Przewłocki R and Przewłocka B (2001) Opioids in chronic pain. Eur J Pharmacol 429:79-91.
25. Rivière PJ (2004) Peripheral κ-opioid agonists for visceral pain. Br J Pharmacol 141:1331-1334.
26. Rowan MP, Ruparel NB, Patwardhan AM, Berg KA, Clarke WP, and Hargreaves KM (2009) Peripheral δ-opioid receptors require priming for functional competence in vivo. Eur J Pharmacol 602:283-287.
27. Samoriski GM and Gross RA (2000) Functional compartmentalization of opioid desensitization in primary sensory neurons. J Pharmacol Exp Ther 294:500-509. (Pubitemid 30490822)
28. Stein C and Zöllner C (2009) Opioids and sensory nerves. Handb Exp Pharmacol 194:495-518.
29. Tan M, Groszer M, Tan AM, Pandya A, Liu X, and Xie CW (2003) Phosphoinositide 3-kinase cascade facilitates μ-opioid desensitization in sensory neurons by altering G-protein-effector interactions. J Neurosci 23:10292-10301. (Pubitemid 37444606)
30. Vanderah TW (2010) Delta and kappa opioid receptors as suitable drug targets for pain. Clin J Pain 26(Suppl 10):S10-S15.
31. Waldhoer M, Bartlett SE, and Whistler JL (2004) Opioid receptors. Annu Rev Biochem 73:953-990. (Pubitemid 39050391)
32. Yamamoto A and Sugimoto Y (2010) Involvement of peripheral μ-opioid receptors in scratching behavior in mice. Eur J Pharmacol 649:336-341.
33. Zöllner C, Mousa SA, Fischer O, Rittner HL, Shaqura M, Brack A, Shakibaei M, Binder W, Urban F, Stein C, et al. (2008) Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J Clin Invest 118:1065-1073. (Pubitemid 351364614)